Abstract
Alzheimer's Disease Diagnosis In article number 2104542 by Hye Yun Kim, YoungSoo Kim, and co-workers, the reliability of blood amyloid-β (Aβ) as an early diagnostic biomarker for Alzheimer's disease (AD) is demonstrated by stimulation of a brain-to-blood efflux of Aβ in AD transgenic mice through oral administration of a chemical that dissociate amyloid plaques in the brain and a subsequent increase of Aβ concentration to be detected in blood.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
